Ceftriaxone intramuscular injection for Neisseria gonorrhoeae

Provenance

Created by SPS, the British Association of Sexual Health and HIV (BASHH), the British HIV Association (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.

Template versions available

Version 3.0 of this PGD template, valid from July 2026, has been published to allow organisations to undertake local governance processes in a timely manner.

Version 2.2 of this PGD template remains currently valid and will be removed from this page on its expiry (30th June 2026).

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

• Ceftriaxone and lidocaine national PGD template accessible V2.2 8.25Opens in a new window · Word · 96 KB
• Ceftriaxone and lidocaine national PGD template accessible V3.0 01.26Opens in a new window · Word · 78 KB

More sexual health PGD templates

• Metronidazole (oral) for use within sexual health services
• Doxycycline post exposure prophylaxis (doxyPEP)
• Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
• Imiquimod 5% w/w cream for anogenital warts
• Podophyllotoxin (topical) for external anogenital warts
• Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
• Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
• Doxycycline for use within sexual health services
• Azithromycin (oral) for use within sexual health services
• Aciclovir (oral) for genital HSV infection
• Clotrimazole cream for candidiasis and candidal balanoposthitis
• Clotrimazole pessaries for candidiasis
• Fluconazole 150mg capsules for candidiasis

All PGD templates

Update history